Related Experiment Video
Updated: Jul 16, 2026

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
Published on: April 6, 2022
Evidence that aging and amyloid promote microglial cell senescence
Barry E Flanary1, Nicole W Sammons, Cuong Nguyen
1Department of Neuroscience, University of Florida College of Medicine, McKnight Brain Institute, Gainesville, Florida 32610-0244, USA.
Abstract:
Advanced age and presence of intracerebral amyloid deposits are known to be major risk factors for development of neurodegeneration in Alzheimer's disease (AD), and both have been associated with microglial activation. However, the specific role of activated microglia in AD pathogenesis remains unresolved. Here we report that microglial cells exhibit significant telomere shortening and reduction of telomerase activity with normal aging in rats, and that in humans there is a tendency toward telomere shortening with presence of dementia. Human brains containing high amyloid loads demonstrate a significantly higher degree of microglial dystrophy than nondemented, amyloid-free control subjects. Collectively, these findings show that microglial cell senescence associated with telomere shortening and normal aging is exacerbated by the presence of amyloid. They suggest that degeneration of microglia is a factor in the pathogenesis of AD.
Insights
Microglial cells experience telomere shortening with aging, a process worsened by amyloid deposits. This cellular aging and degeneration in microglia contribute to the development of Alzheimer
Area of Science:
- Neuroscience
- Cell Biology
- Gerontology
Background:
- Advanced age and amyloid deposits are key risk factors for Alzheimer's disease (AD) neurodegeneration.
- Microglial activation is observed in AD, but its precise role in pathogenesis is unclear.
Purpose of the Study:
- To investigate the impact of aging and amyloid on microglial cell health and function.
- To determine if microglial senescence is linked to Alzheimer's disease development.
Main Methods:
- Analysis of telomere length and telomerase activity in rat microglial cells during normal aging.
- Examination of telomere shortening trends in human brain samples from individuals with and without dementia.
- Assessment of microglial dystrophy in human brains with varying amyloid loads.
Main Results:
- Microglial cells showed significant telomere shortening and reduced telomerase activity with normal aging in rats.
- A trend towards telomere shortening was observed in human brains with dementia.
- Human brains with high amyloid loads exhibited greater microglial dystrophy compared to controls.
Conclusions:
- Microglial cell senescence, characterized by telomere shortening, is a normal aging process.
- This senescence is exacerbated by the presence of amyloid deposits, suggesting a link to AD.
- Microglial degeneration is proposed as a contributing factor in Alzheimer's disease pathogenesis.
More Related Videos
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Mitochondria
Alzheimer Disease l: Introduction
The Effect of Aging on Tissues

